Le Lézard
Classified in: Health
Subjects: TDS, FDA

Qfix® Announces FDA 510(k) Clearance of Encompasstm 15 Channel Head Coil for Siemens 3T MRI Systems

AVONDALE, Pa., Sept. 12, 2019 /PRNewswire/ -- Qfix has received FDA 510(k) clearance for the Encompass 15-Channel Head Coil, a diagnostic imaging device optimized for use with the Encompasstm MR SRS Immobilization Device. 

The Encompass 15-Channel Head Coil provides diagnostic quality images for select Siemens 3T MRI Scanners. The adjustable geometry, 15-Channel coil allows the user to locate the coil elements close to the patient's anatomy. Optimal signal to noise ratio can be obtained across the entire cranium while accommodating the high precision positioning unique to the Encompass device. The Encompass MR SRS Immobilization System is part of the Qfix MRimage and Treattm line of devices, which enables patients to benefit from MR, CT, and Treatment on the same device.  MR images obtained with the Encompass MR SRS Immobilization System can be used for SRS treatment planning, including MR Only and MR Fusion techniques.

"Qfix is excited to receive clearance on our first of its kind MRI coil dedicated for use with our industry leading Encompass SRS system," said Dan Coppens, CEO of Qfix. "This technology enables the clinician to obtain superior MRI images which can be used for SRS treatment planning purposes."

Please visit Qfix at ASTRO Booth #2314 to see the latest innovations and live demonstrations of MR, CT, and treatment solutions during the American Society for Radiation Oncology (ASTRO) annual meeting, September 15-17, 2019.

About Qfix
Qfix is a world leader in radiotherapy dedicated to helping medical professionals provide the best patient care with the world's finest positioning devices designed to enhance the probability of positive patient outcomes. For more information, visit www.Qfix.com.


These press releases may also interest you

at 12:00
In lieu of an in-person update to the media, Dr. Theresa Tam, Canada's Chief Public Health Officer, issued the following statement today: "There have been 105,091 cases of COVID-19 in Canada, including 8,663 deaths. 65% of people have now recovered....

at 11:00
The latest data of the evolution of COVID-19 in Québec reveal 102 new cases over the past 24 hours, bringing the total number of people infected to 55,784. During the same period, 3 new deaths were recorded, to which are added 3 deaths that occurred...

at 10:37
On Friday, the British government announced that, as of July 10th, those travelling from the Commonwealth of Dominica to England need not self-isolate for 14 days. Dominica is one of the 59 countries and 14 British Overseas Territories forming a...

at 03:05
Gilead Sciences, Inc. today announced data from an ongoing Phase 1 study, which showed that a sustained-delivery subcutaneous formulation of the company's investigational, novel inhibitor of HIV-1 capsid function, lenacapavir (GS-6207), sustained...

at 03:05
Gilead Sciences, Inc. today announced data demonstrating the safety and efficacy of the once-daily, single tablet regimen Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) in virologically suppressed...

3 jui 2020
Daiya Foods Inc. is recalling Daiya brand Classic Vanilla Creme Non-Dairy Frozen Dessert from the marketplace because it contains milk which is not declared on the label. People with an allergy to milk should not consume the recalled product...

News published on 12 september 2019 at 16:37 and distributed by: